$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/48
출원번호 US-0258654 (1999-02-26)
발명자 / 주소
  • Patel Mahesh V.
  • Chen Feng-Jing
출원인 / 주소
  • Lipocine, Inc.
대리인 / 주소
    Reed
인용정보 피인용 횟수 : 444  인용 특허 : 22

초록

The present invention relates to triglyceride-free pharmaceutical compositions for delivery of hydrophobic therapeutic agents. Compositions of the present invention include a hydrophobic therapeutic agent and a carrier, where the carrier is formed from a combination of a hydrophilic surfactant and a

대표청구항

[ What is claimed and desired to be secured by United States Letters Patent is:] [1.]1. A capsule for oral administration of a therapeutic agent, containing a composition comprised of:(a) a hydrophobic therapeutic agent having an intrinsic water solubility of less than about 1 wt. % at 25.degree. C.

이 특허에 인용된 특허 (22)

  1. Crooks Michael J. (Chatswood AUX), Clear micellized solutions of fat soluble essential nutrients.
  2. Cavanak Thomas (Biel-Benken CHX), Cyclosporin galenic forms.
  3. Woo Jong S. (Kyunggi-do KRX), Cyclosporin-containing soft capsule compositions.
  4. Lacy Jonathan Ernest (Swindon GBX) Embleton Jonathan Kenneth (Berkshire GBX), Delivery systems for hydrophobic drugs.
  5. Wretlind Karl A. J. (Stockholm SEX) Ajaxon Bengt M. (Uppsala SEX), Emulsion for parenteral administration.
  6. Cavanak Thomas (Oberwil CHX), Galenical compositions.
  7. Story Michael J. (Glenside AUX), Gelatin pharmaceutical formulations.
  8. Walch Hatto (Laupheim -Baustetten DEX) Fleck Monika (Laupheim DEX) Neuer Klaus (Grossschafhausen DEX), Liquid preparations containing cyclosporin and process for preparing same.
  9. Benita Simon (Jerusalem ILX) Levy Menashe (Jerusalem ILX), Medicinal emulsions.
  10. Pittrof Folker,DEX ; Steffen Hans,CHX, Mixed micelles.
  11. Cho Moo J. ; Levy Ralph E. ; Pouletty Philippe J., Oral cyclosporin formulations.
  12. Bhalani Vinayak T. ; Patel Satishchandra P., Pharmaceutical composition for cyclosporines.
  13. Hauer Birgit (Lahr DEX) Meinzer Armin (Freiburg/Munzingen DEX) Posanski Ulrich (Freiburg DEX) Richter Friedrich (Schnbhl-Urtenen CHX), Pharmaceutical compositions comprising cyclosporins.
  14. Hauer Birgit,DEX ; Meinzer Armin,DEX ; Posanski Ulrich,DEX ; Richter Friedrich,CHX, Pharmaceutical compositions comprising cyclosporins.
  15. Jones Christopher Buchan,GBX ; Platt John Henry,GBX, Pharmaceutical compositions of propofol and edetate.
  16. Story Michael J. (Threapwood GB2) Flynn Michael J. (Surrey GB2), Pharmaceutical delivery systems.
  17. Cho Young W. (Chester NJ) Flynn Michael John (Surrey GB2), Pharmaceutical formulations that have a biologically active hydrophilic phase and a chylomicra-containing hydrophobic ph.
  18. Muller Bernd W. W. (Schlotfeldtsberg 14a 2302 Flintbek DEX) Franzky Hans-Jurgen (von-Coels-Str. 1 5100 Aachen DEX) Klln Claus-Jurgen (Eichofstr. 9 2300 Kiel DEX), Pharmaceutical multicomponent systems and method of preparing same.
  19. Schmidt Peter C. (Marburg DEX) Stockebrand Bernd (Monchen-Gladbach DEX) Fischer Gerhard (Eberbach DEX), Pharmaceutical preparation with an active substance of low solubility in water and gastric juices.
  20. Yu Man S. (Rochester NY) Hom Foo S. (Safety Harbor FL) Chakrabarti Sibaprasanna (Oldsmer FL) Huang Chong-Heng (Madison NJ) Patel Mahendra (Swindon GB2), Solvent system enhancing the solubility of pharmaceuticals for encapsulation.
  21. Kaufman Robert J. (University City MO) Richard Thomas J. (University City MO) Fuhrhop Ralph W. (St. Louis MO), Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same.
  22. Liversidge Gary G. (West Chester PA) Cundy Kenneth C. (Pottstown PA) Bishop John F. (Rochester NY) Czekai David A. (Honeoye Falls NY), Surface modified drug nanoparticles.

이 특허를 인용한 특허 (444)

  1. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Nachaegari, Satish Kumar; Chidambaram, Nachiappan; Patel, Mahesh V., 17-Hydroxyprogesterone ester containing oral compositions and related methods.
  2. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Nachaegari, Satish Kumar; Chidambaram, Nachiappan; Patel, Mahesh V., 17-hydroxyprogesterone ester containing oral compositions and related methods.
  3. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Nachaegari, Satish Kumar; Chidambaram, Nachiappan; Patel, Mahesh V., 17-hydroxyprogesterone ester containing oral compositions and related methods.
  4. Giliyar, Chandrashekar; Venkateshwaran, Srinivansan; Chickmath, Basawaraj; Nachaegari, Satish Kumar; Chidambaram, Nachiappan; Patel, Mahesh V., 17-hydroxyprogesterone ester-containing oral compositions and related methods.
  5. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Nachaegari, Satish Kumar; Chidambaram, Nachiappan; Patel, Mahesh V., 17-hydroxyprogesterone ester-containing oral compositions and related methods.
  6. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Nachaegari, Satish Kumar; Nachiappan, Chidambaram; Patel, Mahesh V., 17-hydroxyprogesterone ester-containing oral compositions and related methods.
  7. García Collazo, Ana Maria; Eckland, David John Augustus; Pizcueta Lalanza, Maria Pilar; Martinell Pedemonte, Marc, 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders.
  8. García Collazo, Ana María; Eckland, David John Augustus; Pizcueta Lalanza, Maria Pilar; Martinell Pedemonte, Marc, 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders.
  9. Du, Jinfa; Sofia, Michael Joseph, 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections.
  10. Du, Jinfa; Sofia, Michael Joseph, 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections.
  11. Gizurarson, Sveinbjorn; Olafsdottir, Sigridur; Kristinsson, Jakob Lindal; Hrafnkelsdottir, Kolbrun; Olafsson, David Rurik; Ingolfsson, Oddur; Ingimundardottir, Ellen Ruth, Absorption promoting agent.
  12. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Abuse deterrent compositions and methods of making same.
  13. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Abuse deterrent compositions and methods of making same.
  14. Dharmadhikari, Nitin Bhalachandra; Zala, Yashoraj Rupsinh; Shanghvi, Dilip, Abuse deterrent immediate release coated reservoir solid dosage form.
  15. Dharmadhikari, Nitin Bhalachandra; Zala, Yashoraj Rupsinh; Shanghvi, Dilip, Abuse deterrent immediate release coated reservoir solid dosage form.
  16. Shimizu, Hideaki; Uchida, Miyuki; Sawada, Seigo; Kaneda, Norimasa; Matsumoto, Tsuneo, Acid addition salt of irinotecan.
  17. Pauls, Heinz W.; Ramnauth, Jailall; Sampson, Peter; Toro, Andras, Acrylamide derivatives as Fab I inhibitors.
  18. Pauls, Heinz W.; Ramnauth, Jailall; Sampson, Peter; Toro, Andras, Acrylamide derivatives as Fab I inhibitors.
  19. Chaudry, Imtiaz; Banerjee, Partha, Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease.
  20. Chaudry, Imtiaz; Banerjee, Partha, Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma.
  21. Parikh, Indu; Moussa, Iskandar; Carrier, Alain, Anticancer compositions.
  22. Daute,Peter; Brand,Ernst Udo, Antifogging agent for plastics.
  23. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  24. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  25. Perricone, Nicholas V., Brain and neural treatments comprising peptides and other compositions.
  26. Perricone, Nicholas V., Brain and neural treatments comprising peptides and other compositions.
  27. Perricone, Nicholas V., Brain and neural treatments comprising peptides and other compositions.
  28. Perricone, Nicholas V., Brain and neural treatments comprising peptides and other compositions.
  29. Perricone, Nicholas V., Cancer treatments and compositions for use thereof.
  30. Perricone, Nicholas V., Cancer treatments and compositions for use thereof.
  31. Perricone, Nicholas V., Cancer treatments and compositions for use thereof.
  32. Ankner, Charles Everett, Cannabinod formulation for the sedation of a human or animal.
  33. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  34. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  35. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  36. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  37. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  38. Mukai,Tadashi; Tomohira,Yuso; Toda,Masafumi; Yamada,Keigo; Oka,Yoshikazu, Cilostazol preparation.
  39. Johnson, Candace S.; Trump, Donald L., Combination chemotherapy.
  40. McPhillips, Andrea M; Economou, Julia J; Dedhiya, Mahendra G; Wynne, Beverly Ann, Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent.
  41. Perricone, Nicholas V., Compositions and methods for affecting mood states.
  42. Perricone, Nicholas V., Compositions and methods for affecting mood states.
  43. Perricone, Nicholas V., Compositions and methods for affecting mood states.
  44. Mahesh V. Patel ; Feng-Jing Chen, Compositions and methods for improved delivery of hydrophobic agents.
  45. Cowley, Michael A.; McKinney, Anthony A.; Tollefson, Gary, Compositions and methods for increasing insulin sensitivity.
  46. Cowley, Michael A.; McKinney, Anthony A.; Tollefson, Gary, Compositions and methods for increasing insulin sensitivity.
  47. Bannister, Robin Mark; Brew, John; Dilly, Suzanne Jane; Stoloff, Gregory Alan; Caparros Wanderley, Wilson, Compositions and methods for treating cardiovascular diseases.
  48. Bannister, Robin Mark; Brew, John; Dilly, Suzanne Jane; Stoloff, Gregory Alan; Caparros-Wanderley, Wilson, Compositions and methods for treating cardiovascular diseases.
  49. Bannister, Robin Mark; Brew, John; Dilly, Suzanne Jane; Stoloff, Gregory Alan; Caparros-Wanderley, Wilson, Compositions and methods for treating cardiovascular diseases.
  50. Bannister, Robin M.; Brew, John; Caparros-Wanderely, Wilson; Dilly, Suzanne J.; Pleguezeulos Mateo, Olga; Stoloff, Gregory A., Compositions and methods for treating chronic inflammation and inflammatory diseases.
  51. Bannister, Robin M.; Brew, John; Caparros-Wanderely, Wilson; Dilly, Suzanne J.; Pleguezeulos Mateo, Olga; Stoloff, Gregory A., Compositions and methods for treating chronic inflammation and inflammatory diseases.
  52. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Mateo, Olga Pleguezuelos, Compositions and methods for treating chronic inflammation and inflammatory diseases.
  53. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Pleguezuelos Mateo, Olga, Compositions and methods for treating chronic inflammation and inflammatory diseases.
  54. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Pleguezuelos Mateo, Olga, Compositions and methods for treating chronic inflammation and inflammatory diseases.
  55. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Pleguezuelos Mateo, Olga, Compositions and methods for treating chronic inflammation and inflammatory diseases.
  56. Bannister, Robin M.; Brew, John, Compositions and methods for treating inflammatory pain.
  57. Bannister, Robin M.; Brew, John, Compositions and methods for treating severe pain.
  58. Bannister, Robin M.; Brew, John, Compositions and methods for treating severe pain.
  59. Bannister, Robin M.; Brew, John, Compositions and methods for treating severe pain.
  60. Perricone, Nicholas V., Compositions and methods for treatment of osteoporosis and other indications.
  61. Perricone, Nicholas V., Compositions and methods for treatment of osteoporosis and other indications.
  62. Perricone, Nicholas V., Compositions and methods for treatment of osteoporosis and other indications.
  63. Perricone, Nicholas V., Compositions and methods for treatment of osteoporosis and other indications.
  64. Norton, Richard L.; Zhou, Mingxing, Compositions comprising buprenorphine.
  65. Hodge, Robert Emil; Webster, Jeffrey Douglas; Moriarty, Robert M., Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits.
  66. Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum, Compositions comprising multiple bioactive agents, and methods of using the same.
  67. Jerussi,Thomas P.; Fang,Qun K., Compositions comprising zopiclone derivatives and methods of making and using the same.
  68. Weber, Eckard; Cowley, Michael Alexander, Compositions for affecting weight loss.
  69. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Compositions for deterring abuse of opioid containing dosage forms.
  70. Yang, Meidong; Chen, Haigang, Compositions for increasing solubility of azole drug compounds that are poorly soluble in water.
  71. Bannister, Robin Mark; Brew, John; Dilly, Suzanne Jane; Stoloff, Gregory Alan; Caparros-Wanderley, Wilson, Compositions for treating cardiovascular diseases.
  72. Bannister, Robin M.; Brew, John; Caparros-Wanderely, Wilson; Dilly, Suzanne J.; Pleguezeulos Mateo, Olga; Stoloff, Gregory A., Compositions for treating chronic inflammation and inflammatory diseases.
  73. Bannister, Robin Mark; Brew, John; Caparros-Wanderley, Wilson; Stoloff, Gregory Alan; Dilly, Suzanne Jane; Szucs, Gemma; Pleguezuelos Mateo, Olga, Compositions for treating chronic inflammation and inflammatory diseases.
  74. Naicker, Selvaraj A.; Yatscoff, Randall W.; Foster, Robert T., Cyclosporin analog formulations.
  75. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  76. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  77. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  78. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  79. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  80. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  81. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  82. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  83. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  84. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  85. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  86. Legora, Michela; Mailland, Federico, Cyclosporin-based pharmaceutical compositions.
  87. Schaeffler, Achim, Delayed-release glucocorticoid treatment of rheumatoid disease.
  88. Schaeffler, Achim, Delayed-release glucocorticoid treatment of rheumatoid disease.
  89. Delmarre, David; Martina, Marie-Sophie Lina; Vertommen, Jan Emiel Godelieve, Delivery carrier.
  90. Tamor, Mildred Estrada; Dowdell, David Peter, Dispersion, gel and emulsification system.
  91. Niitsu, Yoshiro; Yu, Lei; Liu, Jian; Zhao, Gang; Ma, Nianchun; Van, Sang, Drug carriers.
  92. Wang, Lixiao, Drug releasing coatings for balloon catheters.
  93. Wang, Lixiao, Drug releasing coatings for balloon catheters.
  94. Wang, Lixiao, Drug releasing coatings for balloon catheters.
  95. Wang, Lixiao, Drug releasing coatings for balloon catheters.
  96. Wang, Lixiao, Drug releasing coatings for medical devices.
  97. Wang, Lixiao, Drug releasing coatings for medical devices.
  98. Wang, Lixiao, Drug releasing coatings for medical devices.
  99. Wang, Lixiao, Drug releasing coatings for medical devices.
  100. Wang, Lixiao, Drug releasing coatings for medical devices.
  101. Wang, Lixiao, Drug releasing coatings for medical devices.
  102. Wang, Lixiao, Drug releasing coatings for medical devices.
  103. Wang, Lixiao, Drug releasing coatings for medical devices.
  104. Wang, Lixiao, Drug releasing coatings for medical devices.
  105. Wang, Lixiao, Drug releasing coatings for medical devices.
  106. Wang, Lixiao, Drug releasing coatings for medical devices.
  107. Wang, Lixiao, Drug releasing coatings for medical devices.
  108. Wang, Lixiao, Drug releasing coatings for medical devices.
  109. Wang, Lixiao, Drug releasing coatings for medical devices.
  110. Wang, Lixiao, Drug releasing coatings for medical devices.
  111. Wang, Lixiao, Drug releasing coatings for medical devices.
  112. Wang, Lixiao, Drug releasing coatings for medical devices.
  113. Wang, Lixiao, Drug releasing coatings for medical devices.
  114. Chen, Feng-Jing; Patel, Mahesh V., Emulsion compositions for polyfunctional active ingredients.
  115. Dixit, Manesh; Cheng, Xiu-Xiu; Nangia, Avinash; Chen, Chin Ming, Extended release venlafaxine formulation.
  116. Dixit,Manesh; Cheng,Xiu Xiu; Nangia,Avinash; Chen,Chih Ming, Extended release venlafaxine formulation.
  117. Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.; Dewolf, Jr., Walter E.; Jakas, Dalia R., FAB I inhibitors.
  118. Burgess, Walter J.; Jakas, Dalia R.; Huffman, William F.; Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N., Fab I inhibitors.
  119. Burgess, Walter J.; Jakas, Dalia R.; Huffman, William F.; Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N., Fab I inhibitors.
  120. Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.; Dewolf, Jr., Walter E.; Jakas, Dalia R., Fab I inhibitors.
  121. Mazess,Richard B.; Driscoll,Jeffrey W.; Goldensoph,Creighton Reed; LeVan,Leon W., Formulation for lipophilic agents.
  122. Gandhi, Rajesh; Manikonda, Sreekanth; Jana, Arun; Kunte, Sameer Shrinivas, Formulations comprising triptan compounds.
  123. Gandhi, Rajesh; Manikonda, Sreekanth; Jana, Arun; Kunte, Sameer Shrinivas, Formulations comprising triptan compounds.
  124. Gandhi, Rajesh; Manikonda, Sreekanth; Jana, Arun; Kunte, Sameer Shrinivas, Formulations comprising triptan compounds.
  125. Mosher, Gerold L.; Johnson, Karen T.; Gayed, Atef A., Formulations containing amiodarone and sulfoalkyl ether cyclodextrin.
  126. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  127. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  128. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  129. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  130. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  131. Wasan, Kishor M.; Wasan, Ellen K., Formulations for the oral administration of therapeutic agents and related methods.
  132. Hodge, Robert Emil; Webster, Jeffrey Douglas, Formulations of deoxycholic acid and salts thereof.
  133. Hodge, Robert Emil; Webster, Jeffrey Douglas, Formulations of deoxycholic acid and salts thereof.
  134. Hodge, Robert Emil; Webster, Jeffrey Douglas, Formulations of deoxycholic acid and salts thereof.
  135. Hodge, Robert Emil; Webster, Jeffrey Douglas; Moriarty, Robert M., Formulations of deoxycholic acid and salts thereof.
  136. Wright, Curtis; Carr, Daniel B.; Mermelstein, Fred H., Formulations of low dose diclofenac and beta-cyclodextrin.
  137. Wright, Curtis; Carr, Daniel B.; Mermelstein, Fred H., Formulations of low dose diclofenac and beta-cyclodextrin.
  138. Berner, Bret; Hou, Sui Yuen Eddie, Gastric retained gabapentin dosage form.
  139. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  140. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  141. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  142. Berner, Bret; Hou, Sui Yuen Eddie; Gana, Theophilus J.; Cramer, Marilou S., Gastric retentive gabapentin dosage forms and methods for using same.
  143. Moe, Derek; Agarwal, Vikas; Habib, Walib, Generally linear effervescent oral fentanyl dosage form and methods of administering.
  144. Perricone, Nicholas V., Hair treatment systems and methods using peptides and other compositions.
  145. Perricone, Nicholas V., Hair treatment systems and methods using peptides and other compositions.
  146. Perricone, Nicholas V., Hair treatment systems and methods using peptides and other compositions.
  147. Berman, Judd M.; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall; Manning, David Douglas; Surman, Matthew D.; Xie, Dejian; Decornez, Helene Y., Heterocyclic compounds, methods of making them and their use in therapy.
  148. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  149. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  150. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  151. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  152. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  153. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  154. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  155. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V, High-strength testosterone undecanoate compositions.
  156. Trieu, Vuong; De, Tapas K., Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods.
  157. Perricone, Nicholas V., Immune modulation using peptides and other compositions.
  158. Perricone, Nicholas V., Immune modulation using peptides and other compositions.
  159. Perricone, Nicholas V., Immune modulation using peptides and other compositions.
  160. Perricone, Nicholas V., Immune modulation using peptides and other compositions.
  161. Fort, James J.; Krill, Steven L.; Law, Devalina; Qiu, Yihong; Schmitt, Eric A., Inhibitors of crystallization in a solid dispersion.
  162. Mishra,Awadhesh K.; Pace,Gary W.; Vachon,Michael G, Injectable aqueous dispersions of propofol.
  163. Mishra,Awadhesh K.; Pace,Gary W.; Vachon,Michael G., Injectable aqueous dispersions of propofol.
  164. Norton, Richard L.; Watkins, Andrew; Zhou, Mingxing, Injectable flowable composition comprising buprenorphine.
  165. McKinney, Anthony; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Layered pharmaceutical formulations.
  166. McKinney, Anthony; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Layered pharmaceutical formulations.
  167. Fujisaki,Jiro; Konno,Hajime; Kasai,Akihiro; Ohtomo,Kazumi, Liposome preparations.
  168. Wang, Lixiao, Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent.
  169. Wang, Lixiao, Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent.
  170. Wang, Lixiao, Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent.
  171. Wang, Lixiao, Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent.
  172. Wang, Lixiao, Medical device rapid drug releasing coatings comprising oils, fatty acids and/or lipids.
  173. Wang, Lixiao, Medical device rapid drug releasing coatings comprising oils, fatty acids and/or lipids.
  174. Wang, Lixiao, Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids.
  175. Wang, Lixiao, Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids.
  176. Perricone, Nicholas V., Memory or learning improvement using peptide and other compositions.
  177. Perricone, Nicholas V., Memory or learning improvement using peptide and other compositions.
  178. Perricone, Nicholas V., Memory or learning improvement using peptide and other compositions.
  179. Ueki, Yosuke; Suzuki, Yasuyuki; Fujioka, Satoshi, Method for stabilizing anti-dementia drug.
  180. Ueki, Yosuke; Suzuki, Yasuyuki; Fujioka, Satoshi, Method for stabilizing anti-dementia drug.
  181. Cevc, Gregor; Richardsen, Holger; Weiland Waibel, Andrea, Method for the improvement of transport across adaptable semi-permeable barriers.
  182. Cevc,Gregor; Richardsen,Holger; Weiland Waibel,Andrea, Method for the improvement of transport across adaptable semi-permeable barriers.
  183. Wang, Jeffrey; Malinoff, Harrison; Wang, Lixiao; Barry, Christopher M.; Wahr, Dennis W.; Naisbitt, Scott R., Methods and apparatuses for coating balloon catheters.
  184. Wang, Jeffrey; Malinoff, Harrison; Wang, Lixiao; Barry, Christopher M.; Wahr, Dennis W.; Naisbitt, Scott R., Methods and apparatuses for coating balloon catheters.
  185. Wang, Jeffrey; Malinoff, Harrison; Wang, Lixiao; Barry, Christopher M.; Wahr, Dennis W.; Naisbitt, Scott R., Methods and apparatuses for coating balloon catheters.
  186. Leech, Ronald L.; Hall Yung, Rachelle L.; Brzeczko, Albert W., Methods and compositions for deterring abuse.
  187. Leech, Ronald L.; Hall Yung, Rachelle L.; Brzeczko, Albert W., Methods and compositions for deterring abuse.
  188. Yang, Meidong; Chen, Haigang, Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water.
  189. Perricone, Nicholas V., Methods and compositions for muscular and neuromuscular diseases.
  190. Perricone, Nicholas V., Methods and compositions for muscular and neuromuscular diseases.
  191. Perricone, Nicholas V., Methods and compositions for muscular and neuromuscular diseases.
  192. Perricone, Nicholas V., Methods and compositions for muscular and neuromuscular diseases.
  193. Brzeczko, Albert W.; Hollenbeck, R. Gary, Methods and compositions for self-regulated release of active pharmaceutical ingredient.
  194. Brzeczko, Albert W.; Hollenbeck, R. Gary, Methods and compositions for self-regulated release of active pharmaceutical ingredient.
  195. Kolodney, Michael S.; Rotunda, Adam M., Methods and compositions for the non-surgical removal of fat.
  196. Yam, Nyomi V.; Reyes, Iran; Davar, Nipun; Ayer, Atul D.; Lee, Julie; Seroff, Sonya; Gupta, Suneel K.; Sathyan, Gayatri, Methods and dosage forms for controlled delivery of paliperidone and risperidone.
  197. Tidmarsh, George; Golombik, Barry L.; Sharma, Puneet, Methods and medicaments for administration of ibuprofen.
  198. Kolodney, Michael S.; Rotunda, Adam M., Methods and related compositions for reduction of fat.
  199. Kolodney, Michael S.; Rotunda, Adam M., Methods and related compositions for reduction of fat and skin tightening.
  200. Kolodney, Michael S.; Rotunda, Adam M., Methods and related compositions for reduction of fat and skin tightening.
  201. Kolodney, Michael S.; Rotunda, Adam M., Methods and related compositions for the non-surgical removal of fat.
  202. Perricone, Nicholas V., Methods and systems for treating or preventing cancer.
  203. Perricone, Nicholas V., Methods and systems for treating or preventing cancer.
  204. Perricone, Nicholas V., Methods and systems for treating or preventing cancer.
  205. Perricone, Nicholas V., Methods and systems for treating or preventing cancer.
  206. Perricone, Nicholas V., Methods and systems for treatment of inflammatory diseases with nitric oxide.
  207. Perricone, Nicholas V., Methods and systems for treatment of inflammatory diseases with nitric oxide.
  208. Perricone, Nicholas V., Methods and systems for treatment of inflammatory diseases with nitric oxide.
  209. Perricone, Nicholas V., Methods and systems for treatment of inflammatory diseases with nitric oxide.
  210. McKinney, Anthony A.; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Methods for administering weight loss medications.
  211. McKinney, Anthony; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Methods for administering weight loss medications.
  212. Perricone, Nicholas V.; Potini, Chim, Methods of delivering stable topical drug compositions.
  213. Perricone, Nicholas V.; Potini, Chim, Methods of delivering stable topical drug compositions.
  214. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  215. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  216. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  217. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  218. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  219. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  220. Dunayevich, Eduardo; Tollefson, Gary, Methods of providing weight loss therapy in patients with major depression.
  221. Klassen, Preston; Taylor, Kristin, Methods of treating overweight and obesity.
  222. Berner, Bret; Hou, Sui Yuen Eddie, Methods of treatment using a gastric retained gabapentin dosage.
  223. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  224. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  225. Berner, Bret; Hou, Sui Yuen Eddie, Methods of treatment using a gastric retained gabapentin dosage form.
  226. Cevc,Gregor; Vierl,Ulrich, NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery.
  227. Khopade, Ajay Jaysingh; Bhowmick, Subhas Balaram; Arulsudar, Natarajan, Nanodispersion.
  228. Khopade, Ajay Jaysingh; Arulsudar, Natarajan; Bhowmick, Subhas Balaram, Nanodispersion of a drug and process for its preparation.
  229. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  230. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  231. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  232. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  233. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  234. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  235. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  236. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  237. Bernick, Brian A.; Persicaner, Peter H. R.; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  238. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
  239. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
  240. Nabeta, Kiichiro, Non-aqueous taxane nanodispersion formulations and methods of using the same.
  241. Cevc, Gregor; Chopra, Amla, Non-invasive vaccination through the skin.
  242. Bao, Donghui; Chang, Wonsuk; Nagarathnam, Dhanapalan; Sofia, Michael Joseph, Nucleoside analogs.
  243. Du, Jinfa; Nagarathnam, Dhanapalan; Pamulapati, Ganapati Reddy; Ross, Bruce S.; Sofia, Michael Joseph, Nucleoside cyclicphosphates.
  244. Du, Jinfa; Nagarathnam, Dhanapalan; Pamulapati, Ganapati Reddy; Ross, Bruce S.; Sofia, Michael Joseph, Nucleoside cyclicphosphates.
  245. Sofia, Michael Joseph; Du, Jinfa; Wang, Peiyuan; Nagarathnam, Dhanapalan, Nucleoside phosphoramidates.
  246. Sofia, Michael Joseph; Du, Jinfa; Wang, Peiyuan; Nagarathnam, Dhanapalan, Nucleoside phosphoramidates.
  247. Baheti, Ankit; Padhi, Bijay Kumar; Vakada, Supritha; Raghuvanshi, Rajeev Singh, Oral composition of celecoxib for treatment of pain.
  248. Ahmed, Salah U.; Diliberti, Charles E.; Vattikonda, Chandra; Gorukanti, Sudhir R.; Gupta, Sanjeev K., Oral dosage forms comprising progesterone and methods of making and using the same.
  249. Dudley, Robert E.; Constantinides, Panayiotis P., Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.
  250. Dudley, Robert E.; Constantinides, Panayiotis P., Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.
  251. Hong, Ki Whan, PTEN inhibitor or Maxi-K channels opener.
  252. Hong, Ki Whan, PTEN inhibitor or Maxi-K channels opener.
  253. Hong, Ki Whan, PTEN inhibitor or Maxi-K channels opener.
  254. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  255. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  256. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  257. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  258. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  259. Dudley, Robert E.; Drouin, Dominique, Pharmaceutical composition and method for treating hypogonadism.
  260. Dudley, Robert E.; Drouin, Dominique, Pharmaceutical composition and method for treating hypogonadism.
  261. Mulye, Nirmal, Pharmaceutical composition containing water soluble drug.
  262. Mulye, Nirmal, Pharmaceutical composition containing water soluble drug.
  263. Patel, Satishchandra P., Pharmaceutical compositions.
  264. Gyurik, Robert J.; Reppucci, Carl, Pharmaceutical compositions and methods for insulin treatment.
  265. Gyurik,Robert J.; Reppucci,Carl, Pharmaceutical compositions and methods for insulin treatment.
  266. Gyurik,Robert J.; Reppucci,Carl, Pharmaceutical compositions and methods for peptide treatment.
  267. Tien, Walter L.; Graham, Richard S.; Chang, James N., Pharmaceutical compositions comprising cyclosporins.
  268. Tien,Walter L.; Graham,Richard; Chang,James N., Pharmaceutical compositions comprising cyclosporins.
  269. Merkus, Franciscus Wilhelmus Henricus Maria, Pharmaceutical compositions comprising midazolam in a high concentration.
  270. Mosher, Gerold L.; Machatha, Stephen G.; Cushing, Daniel J., Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same.
  271. Mosher, Gerold L.; Machatha, Stephen G.; Cushing, Daniel J., Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same.
  272. Mosher, Gerold L; Machatha, Stephen G.; Cushing, Daniel J., Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same.
  273. Babcock, Walter C.; Friesen, Dwayne T.; Shanker, Ravi M.; Smithey, Daniel T., Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials.
  274. Babcock, Walter C.; Friesen, Dwayne T.; Shanker, Ravi M.; Smithey, Daniel T., Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials.
  275. Perlman, Michael E.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne Thomas; Rabenstein, Mark D.; Smithey, Dan Tod, Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials.
  276. Gupta,Shanker; Maurer,Barry J.; Reynolds,C. Patrick; Vishnuvajjala,B. Rao, Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same.
  277. Tawa, Mark; Remenar, Julius; Peterson, Matthew L.; Almarsson, Örn; Guzman, Hector; Chen, Hongming; Oliveira, Mark, Pharmaceutical compositions with improved dissolution.
  278. Dudley, Robert E.; Constantinides, Panayiotis P., Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same.
  279. Dudley, Robert E.; Constantinides, Panayiotis P., Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same.
  280. Dudley, Robert E.; Constantinides, Panayiotis P., Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same.
  281. Corvari,Vincent; Grandolfi,George; Parikh,Alpa, Pharmaceutical formulations of modafinil.
  282. Corvari,Vincent; Grandolfi,George; Parikh,Alpa, Pharmaceutical formulations of modafinil.
  283. Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R., Pharmaceutical formulations of modafinil.
  284. Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R., Pharmaceutical formulations of modafinil.
  285. Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R., Pharmaceutical formulations of modafinil.
  286. Hall, Warren; Olmstead, Kay; Weston, Laura, Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  287. Olmstead, Kay; Hall, Warren; Proehl, Gerald T., Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  288. Olmstead, Kay; Hall, Warren; Proehl, Gerald T., Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  289. Tawa, Mark; Almarsson, Örn; Remenar, Julius, Pharmaceutical propylene glycol solvate compositions.
  290. Tawa, Mark; Almarsson, Örn; Remenar, Julius, Pharmaceutical propylene glycol solvate compositions.
  291. DeBoeck, Arthur M.; Vanderbist, Francis; Servais, Cecile; Baudier, Philippe, Pharmaceutical semi-solid composition of isotretinoin.
  292. Vanderbist, Francis; Servais, Cecile; Baudier, Philippe, Pharmaceutical semi-solid composition of isotretinoin.
  293. Vanderbist, Francis; Servais, Cécile; Baudier, Philippe, Pharmaceutical semi-solid composition of isotretinoin.
  294. Vanderbist, Francis; Servais, Cécile; Baudier, Phillippe, Pharmaceutical semi-solid composition of isotretinoin.
  295. Vanderbist,Francis; Servais,Cecile; Baudier,Philippe, Pharmaceutical semi-solid composition of isotretinoin.
  296. Jacobs, Martin J.; McIntyre, Bradley T.; Parikh, Alpa; Patel, Piyush R., Pharmaceutical solutions of modafinil compounds.
  297. Tawa, Mark; Almarsson, Örn; Remenar, Julius, Pharmaceutically acceptable propylene glycol solvate of naproxen.
  298. Thassu,Deepak K., Pharmaceutically active particles of a monomodal particle size distribution and method.
  299. Simkin,Guillermo O.; Richter,Anna M.; Hunt,David W. C.; North,John Robert; Lutwyche,Peter; Boch,Ronald Erwin, Photodynamic therapy for the treatment of hair loss.
  300. Simkin,Guillermo O.; Richter,Anna M.; Hunt,David W. C.; North,John Robert; Lutwyche,Peter; Boch,Ronald Erwin; Houle,Jean Marie, Photodynamic therapy for the treatment of hair loss.
  301. Perricone, Nicholas V., Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery.
  302. Perricone, Nicholas V., Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery.
  303. Perricone, Nicholas V., Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery.
  304. Feinerman, Gregg; Barth, Neil; Schiffman, Rhett M.; Barnett, Pamela S., Prevention and treatment of ocular side effects with a cyclosporin.
  305. Feinerman, Gregg; Barth, Neil; Schiffman, Rhett M.; Barnett, Pamela S., Prevention and treatment of ocular side effects with a cyclosporin.
  306. Feinerman, Gregg; Barth, Neil; Schiffman, Rhett; Barnett, Pamela S., Prevention and treatment of ocular side effects with a cyclosporin.
  307. Partridge, John J.; Colucci, John; Gareau, Yves; Therien, Michel; Zamboni, Robert; Hafkin, Barry; Marfat, Anthony; Zaghdane, Helmi, Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide.
  308. Partridge, John J.; Colucci, John; Gareau, Yves; Therien, Michel; Zamboni, Robert; Hafkin, Barry; Marfat, Anthony; Zaghdane, Helmi, Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide.
  309. Nachaegari, Satish Kumar; Giliyar, Chandrashekar; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Progesterone containing oral dosage forms and kits.
  310. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Cacace, Janice Louise; Thorsteinsson, Thorsteinn; Sancilio, Frederick D., Progesterone formulations.
  311. Chang, Wonsuk; Naduthambi, Devan; Nagarathnam, Dhanapalan; Pamulapati, Ganapati Reddy; Ross, Bruce S.; Sofia, Michael Joseph; Zhang, Hai-Ren, Purine nucleoside phosphoramidate.
  312. Grimshaw,Michael N.; Barbieri,Donald J.; Vizzini,Louise M.; Marsh,Steve F., Rapidly disintegrable tablets.
  313. Grimshaw,Michael N.; Barbieri,Donald J.; Vizzini,Louise M.; Marsh,Steve F., Rapidly disintegrable tablets.
  314. Kottayil, S. George; Zhu, Zhongyuan; Goskonda, Venkat R., Room-temperature stable dronabinol formulations.
  315. Pauls, Henry; Ramnauth, Jailall, Salts, prodrugs and polymorphs of fab I inhibitors.
  316. Pauls, Henry; Ramnauth, Jailall, Salts, prodrugs and polymorphs of fab I inhibitors.
  317. Berndl, Gunther; Breitenbach, Jörg; Heger, Robert; Stadler, Michael; Wilke, Peter; Rosenberg, Jörg, Self-emulsifying active substance formulation and use of this formulation.
  318. Berndl, Gunther; Breitenbach, Jörg; Heger, Robert; Stadler, Michael; Wilke, Peter; Rosenberg, Jörg, Self-emulsifying active substance formulation and use of this formulation.
  319. Fort,James J.; Krill,Steven L.; Law,Devalina; Qiu,Yihong; Porter,William R.; Schmitt,Eric A., Solid dispersion pharamaceutical formulations.
  320. Berndl, Gunther; Rosenberg, Joerg; Liepold, Bernd; Breitenbach, Joerg; Reinhold, Ulrich; Alani, Laman; Ghosh, Soumojeet, Solid pharmaceutical dosage form.
  321. Rosenberg, Jeorg; Reinhold, Ulrich; Liepold, Bernd; Berndl, Gunther; Breitenbach, Joerg; Alani, Laman; Ghosh, Soumojeet, Solid pharmaceutical dosage form.
  322. Rosenberg, Joerg; Reinhold, Ulrich; Liepold, Bernd; Berndl, Gunther; Breitenbach, Joerg; Alani, Laman; Ghosh, Soumojeet, Solid pharmaceutical dosage form.
  323. Rosenberg, Joerg; Reinhold, Ulrich; Liepold, Bernd; Berndl, Gunther; Breitenbach, Joerg; Alani, Laman; Ghosh, Soumojeet, Solid pharmaceutical dosage form.
  324. Rosenberg, Joerg; Reinhold, Ulrich; Liepold, Bernd; Berndl, Gunther; Breitenbach, Joerg; Alani, Laman; Ghosh, Soumojeet, Solid pharmaceutical dosage form.
  325. Rosenberg, Joerg; Reinhold, Ulrich; Liepold, Bernd; Berndl, Gunther; Breitenbach, Joerg; Alani, Laman; Ghosh, Soumojeet, Solid pharmaceutical dosage form.
  326. Rosenberg, Jöerg; Reinhold, Ulrich; Liepold, Bernd; Berndl, Gunther; Breitenbach, Jörg; Alani, Laman L.; Ghosh, Soumojeet, Solid pharmaceutical dosage formulation.
  327. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  328. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  329. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  330. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  331. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  332. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  333. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  334. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  335. Bannister, Robin M.; Brew, John; Reiley, III, Richard R.; Caparros Wanderley, Wilson, Solid solution compositions and use in chronic inflammation.
  336. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Irani, Neda; Cacace, Janice Louise; Thorsteinsson, Thorsteinn; Sancilio, Frederick D., Soluble estradiol capsule for vaginal insertion.
  337. Wasan, Kishor M.; Wasan, Ellen K., Stabilized formulation for oral administration of therapeutic agents and related methods.
  338. Milley, Christopher J; Peters, Scott E, Stable aqueous suspension.
  339. Dedhiya, Mahendra G.; Economou, Julia J.; McPhillips, Andrea M.; Wynne, Beverley A., Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor.
  340. Xu, Jerry; Tidmarsh, George, Stable compositions of famotidine and ibuprofen.
  341. Xu, Jerry; Tidmarsh, George F., Stable compositions of famotidine and ibuprofen.
  342. Xu, Jerry; Tidmarsh, George F., Stable compositions of famotidine and ibuprofen.
  343. Xu, Jerry; Tidmarsh, George F., Stable compositions of famotidine and ibuprofen.
  344. Xu, Jerry; Tidmarsh, George F., Stable compositions of famotidine and ibuprofen.
  345. White, Tyler Oswald, Stable liquid filled hard capsule comprising beta-hydroxy-beta methylbutyric acid.
  346. Perricone,Nicholas V.; Potini,Chim, Stable topical drug delivery compositions.
  347. Ross, Bruce S.; Sofia, Michael Joseph; Pamulapati, Ganapati Reddy; Rachakonda, Suguna; Zhang, Hai-Ren, Stereoselective synthesis of phosphorus containing actives.
  348. Shadiack, Annette; Persicaner, Peter H. R.; Inskeep, Philip B.; Thorsteinsson, Thorsteinn; Sancilio, Frederick D.; Legassie, Jason D., Steroid hormone pharmaceutical composition.
  349. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  350. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  351. Eichman, Jonathan D.; Hontz, John; Khankari, Rajendra K.; Pather, Sathasivan Indiran; Robinson, Joseph R., Sublingual buccal effervescent.
  352. Pather, S. Indiran; Khankari, Rajendra K.; Eichman, Jonathan D.; Robinson, Joseph R.; Hontz, John, Sublingual buccal effervescent.
  353. Dadey, Eric; Li, Qi; Lindemann, Christopher, Sustained delivery formulations of risperidone compounds.
  354. McKinney, Anthony A.; Tollefson, Gary D.; Soltero, Richard; Dunzo, Thea Elise, Sustained release formulation of naltrexone.
  355. McKinney, Anthony A.; Tollefson, Gary D.; Soltero, Richard; Dunzo, Thea Elise, Sustained release formulation of naltrexone.
  356. Luk, Andrew S.; Junnarkar, Gunjan H.; Chen, Guohua, Sustained release small molecule drug formulation.
  357. Zhou, Mingxing; Norton, Richard L., Sustained-release buprenorphine solutions.
  358. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  359. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  360. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  361. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  362. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  363. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  364. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  365. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  366. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  367. Chun, Byoung-Kwon; Du, Jinfa; Rachakonda, Suguna; Ross, Bruce; Sofia, Michael Joseph; Pamulapati, Ganapati Reddy; Chang, Wonsuk; Zhang, Hai-Ren; Nagarathnam, Dhanapalan, Synthesis of purine nucleosides.
  368. Chun, Byoung-Kwon; Du, Jinfa; Rachakonda, Suguna; Ross, Bruce; Sofia, Michael Joseph; Pamulapati, Ganapati Reddy; Chang, Wonsuk; Zhang, Hai-Ren; Nagarathnam, Dhanpalan, Synthesis of purine nucleosides.
  369. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  370. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  371. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  372. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  373. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  374. Perricone, Nicholas V., Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system.
  375. Perricone, Nicholas V., Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system.
  376. Perricone, Nicholas V., Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system.
  377. Perricone, Nicholas V., Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system.
  378. Perricone, Nicholas V., Techniques and systems for treatment of neuropathic pain and other indications.
  379. Perricone, Nicholas V., Techniques and systems for treatment of neuropathic pain and other indications.
  380. Perricone, Nicholas V., Techniques and systems for treatment of neuropathic pain and other indications.
  381. Perricone, Nicholas V., Techniques and systems for treatment of neuropathic pain and other indications.
  382. Malladi, Ramana; Miller, Jodi, Testosterone gel and method of use.
  383. Malladi, Ramana; Miller, Jodi, Testosterone gel and method of use.
  384. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  385. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  386. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  387. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  388. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  389. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  390. Sargent, Bruce J.; Pauls, Henry; Berman, Judd M.; Ramnauth, Jailall; Sampson, Peter; Toro, Andras; Martin, Fernando J.; Surman, Matthew D.; Decornez, Helene Y.; Manning, David D., Therapeutic agents, and methods of making and using the same.
  391. Wang, Yanfeng; Lee, Benjamin T. K.; Ho, Tony C. Y.; Toh, Melvin K. M., Therapeutic compositions for intranasal administration of zolpidem.
  392. Vergnault, Guy; Grenier, Pascal; Nhamias, Alain; Scherer, Dieter; Beck, Petra; Cancade, Patricia, Topical nanoparticulate spironolactone formulation.
  393. Perricone, Nicholas V.; Sayed, Yousry Abdelrehim, Topical nitric oxide systems and methods of use thereof.
  394. Perricone, Nicholas V.; Sayed, Yousry Abdelrehim, Topical nitric oxide systems and methods of use thereof.
  395. Perricone, Nicholas V.; Sayed, Yousry Abdelrehim, Topical nitric oxide systems and methods of use thereof.
  396. Perricone, Nicholas V., Topical systems and methods for treating sexual dysfunction.
  397. Perricone, Nicholas V., Topical systems and methods for treating sexual dysfunction.
  398. Perricone, Nicholas V., Topical systems and methods for treating sexual dysfunction.
  399. Perricone, Nicholas V., Topical systems and methods for treating sexual dysfunction.
  400. Nangia, Avinash; Verma, Daya D.; Jacob, Jules, Topiramate compositions and methods of enhancing its bioavailability.
  401. Amadio, Julia; Shadiack, Annette; Persicaner, Peter H. R.; Winneker, Richard; Legassie, Jason; Thorsteinsson, Thorsteinn; Ghanta, Ajay, Transdermal cream.
  402. Stinchcomb, Audra L.; Nalluri, Buchi N., Transdermal delivery of cannabidiol.
  403. Stinchcomb, Audra L.; Nalluri, Buchi N., Transdermal delivery of cannabidiol.
  404. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Cacace, Janice Louise; Irani, Neda; Sancilio, Frederick D., Transdermal hormone replacement therapies.
  405. Perricone, Nicholas V., Treatment and prevention of learning and memory disorders.
  406. Perricone, Nicholas V., Treatment and prevention of learning and memory disorders.
  407. Perricone, Nicholas V., Treatment and prevention of learning and memory disorders.
  408. Perricone, Nicholas V., Treatment and prevention of learning and memory disorders.
  409. Wang, Lixiao, Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs.
  410. Wang, Lixiao, Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs.
  411. Perricone, Nicholas V., Treatment of skin and soft tissue infection with nitric oxide.
  412. Perricone, Nicholas V., Treatment of skin and soft tissue infection with nitric oxide.
  413. Perricone, Nicholas V., Treatment of skin and soft tissue infection with nitric oxide.
  414. Perricone, Nicholas V., Treatment of skin and soft tissue infection with nitric oxide.
  415. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  416. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  417. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  418. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  419. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  420. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  421. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  422. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  423. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  424. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  425. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  426. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  427. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  428. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  429. Gorodeski, George; Feng, Ying-Hong; Li, Xin, Truncated proteins as cancer markers.
  430. Gorodeski, George; Feng, Ying-Hong; Li, Xin, Truncated proteins as cancer markers.
  431. Hertelendy,Zsolt Istvan; Weiner,Murray; Howell,Michael; Thomas,Joseph, Urogenital or anorectal transmucosal vaccine delivery system.
  432. Schachtel, Bernard P., Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound.
  433. Schachtel, Bernard P., Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound.
  434. Bernick, Brian A.; Amadio, Julia M., Vaginal inserted estradiol pharmaceutical compositions and methods.
  435. Mirkin, Sebastian; Amadio, Julia M.; Bernick, Brian A., Vaginal inserted estradiol pharmaceutical compositions and methods.
  436. Hedrick, James L.; Lee, Ashlynn L. Z.; Ng, Victor W. L.; Yang, Yi Yan, Vitamin functionalized gel-forming block copolymers for biomedical applications.
  437. Hedrick, James L.; Lee, Ashlynn L. Z.; Ng, Victor W. L.; Yang, Yi Yan, Vitamin functionalized gel-forming block copolymers for biomedical applications.
  438. Hedrick, James L.; Lee, Ashlynn L. Z.; Ng, Victor W. L.; Yang, Yi Yan, Vitamin functionalized gel-forming block copolymers for biomedical applications.
  439. Perricone, Nicholas V., Wound healing using topical systems and methods.
  440. Perricone, Nicholas V., Wound healing using topical systems and methods.
  441. Perricone, Nicholas V., Wound healing using topical systems and methods.
  442. Perricone, Nicholas V., Wound healing using topical systems and methods.
  443. Perricone, Nicholas V., Wound healing using topical systems and methods.
  444. Perricone, Nicholas V., Wound healing using topical systems and methods.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로